Search Results 2451-2460 of 17340 for Selective mutism

  1. Phenotyping In Adolescents - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Subcortical Arousal In Perceptual Awareness - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Social Determinants Of Migrant Health Factors Impacting Prostate Cancer Care And Survivorship Among Sub-Saharan African And Caribbean Immigrant Men - Mayo Clinic

    Social Determinants Of Migrant Health Factors Impacting Prostate Cancer Care And Survivorship Among Sub-Saharan African And Caribbean Immigrant Men · Overview.

  4. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

    A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled ...

  5. Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in NMIBC - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

  7. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...

  8. Pressure-enabled Retrograde Occlusive Therapy With Embolization For Control Of Thyroid Disease (PROTECT Registry)

    Multi-center registry study to evaluate disease-related quality of life outcomes of thyroid embolization via pressure-enabled delivery (PED-TAE). Additional ...

  9. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors - Mayo Clinic

    About this study. A FIH study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of ...

  10. A Study To Assess A Change In Disease Activity And Adverse Events Of Intravenous Etentamig And Daratumumab (Etentamig+D) Compared To Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible For Transplant - Mayo Clinic

    Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) ...